Genomefrontier Therapeutics Au Pty Ltd ABN Report

Genomefrontier Therapeutics Au Pty Ltd (ABN 46 671 468 572) an Australian Private Company with an address in Victoria has had an active ABN from Friday, 15th September 2023 and is registered for GST.

ABN:
46 671 468 572

Status:
ABN Active from 15 September 2023
ACN:
671 468 572

GST:
Registered for GST from 15 September 2023

Location:
Melbourne, Inner City, VIC, 3000

ABN Updated:
29 September 2023